DE60118560D1 - Nicht-nukleosid reverse transkriptase inhibitoren - Google Patents

Nicht-nukleosid reverse transkriptase inhibitoren

Info

Publication number
DE60118560D1
DE60118560D1 DE60118560T DE60118560T DE60118560D1 DE 60118560 D1 DE60118560 D1 DE 60118560D1 DE 60118560 T DE60118560 T DE 60118560T DE 60118560 T DE60118560 T DE 60118560T DE 60118560 D1 DE60118560 D1 DE 60118560D1
Authority
DE
Germany
Prior art keywords
reverse transcriptase
transcriptase inhibitors
nucleoside reverse
nucleoside
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60118560T
Other languages
English (en)
Other versions
DE60118560T2 (de
Inventor
Bruno Simoneau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Canada Ltd
Original Assignee
Boehringer Ingelheim Canada Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Canada Ltd filed Critical Boehringer Ingelheim Canada Ltd
Publication of DE60118560D1 publication Critical patent/DE60118560D1/de
Application granted granted Critical
Publication of DE60118560T2 publication Critical patent/DE60118560T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
DE60118560T 2000-06-16 2001-06-14 Nicht-nukleosid reverse transkriptase inhibitoren Expired - Lifetime DE60118560T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21232900P 2000-06-16 2000-06-16
US212329P 2000-06-16
US25663800P 2000-12-18 2000-12-18
US256638P 2000-12-18
PCT/CA2001/000890 WO2001096338A1 (en) 2000-06-16 2001-06-14 Non-nucleoside reverse transcriptase inhibitors

Publications (2)

Publication Number Publication Date
DE60118560D1 true DE60118560D1 (de) 2006-05-18
DE60118560T2 DE60118560T2 (de) 2006-09-28

Family

ID=26907019

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60118560T Expired - Lifetime DE60118560T2 (de) 2000-06-16 2001-06-14 Nicht-nukleosid reverse transkriptase inhibitoren

Country Status (36)

Country Link
US (1) US6420359B1 (de)
EP (1) EP1294720B1 (de)
JP (1) JP3923894B2 (de)
KR (1) KR20030017540A (de)
CN (1) CN1178939C (de)
AR (1) AR028958A1 (de)
AT (1) ATE322492T1 (de)
AU (2) AU7037001A (de)
BG (1) BG107348A (de)
BR (1) BR0102377A (de)
CA (1) CA2411766C (de)
CZ (1) CZ20024114A3 (de)
DE (1) DE60118560T2 (de)
DK (1) DK1294720T3 (de)
EA (1) EA005598B1 (de)
EE (1) EE200200690A (de)
ES (1) ES2261433T3 (de)
HK (1) HK1057558A1 (de)
HR (1) HRP20021003A2 (de)
HU (1) HUP0301105A2 (de)
IL (1) IL152819A0 (de)
MX (1) MXPA02012205A (de)
MY (1) MY130375A (de)
NO (1) NO323830B1 (de)
NZ (1) NZ523549A (de)
PE (1) PE20020083A1 (de)
PL (1) PL360370A1 (de)
PT (1) PT1294720E (de)
SA (1) SA01220202B1 (de)
SK (1) SK17722002A3 (de)
TW (1) TWI270547B (de)
UA (1) UA74834C2 (de)
UY (1) UY26767A1 (de)
WO (1) WO2001096338A1 (de)
YU (1) YU94202A (de)
ZA (1) ZA200209807B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716836B2 (en) 2001-03-22 2004-04-06 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors
US6673791B2 (en) * 2001-07-30 2004-01-06 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors
US6706706B2 (en) * 2002-03-27 2004-03-16 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
US6806265B2 (en) * 2002-05-16 2004-10-19 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
US6759533B2 (en) * 2002-06-28 2004-07-06 Boehringer Ingelheim Pharmaceuticals, Inc. Process and intermediates for making non-nucleoside HIV-1 reverse transcriptase inhibitors
US7642277B2 (en) 2002-12-04 2010-01-05 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
US20040152625A1 (en) * 2002-12-16 2004-08-05 Boehringer Ingelheim International Gmbh Method for improving the pharmacokinetics of an NNRTI
WO2004087140A1 (en) * 2003-03-27 2004-10-14 Boehringer Ingelheim International Gmbh Antiviral combination of a dipyridodiazepinone and a further antiretroviral compound
US7309700B2 (en) * 2004-04-02 2007-12-18 Boehringer Ingelheim International Gmbh Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2′,3′-e] [1,4]diazepin-6-one
US20060025480A1 (en) 2004-08-02 2006-02-02 Boehringer Ingelheim International Gmbh Benzoic acid derivatives as non nucleoside reverse transcriptase inhibitors
US7151174B2 (en) 2004-11-05 2006-12-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process for making a non-nucleoside HIV-1 reverse transcriptase inhibitor
WO2007067844A1 (en) * 2005-12-05 2007-06-14 Boehringer Ingelheim International Gmbh Process for making 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6h-di pyrido[3,2-b:2',3'-e][1,4]diazepin-6-one
EP2085390A1 (de) 2008-01-31 2009-08-05 Institut National De La Sante Et De La Recherche Medicale (Inserm) Markierte Analoge von Halobenzamiden als multimodale Radiopharmazeutika und ihre Vorläufer
AU2010234241A1 (en) * 2009-04-09 2011-09-08 Boehringer Ingelheim International Gmbh Inhibitors of HIV replication

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366972A (en) * 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
US5705499A (en) * 1995-10-06 1998-01-06 Boehringer Ingelheim Pharmaceuticals, Inc. 8-arylalkyl- and 8-arylheteroalkyl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-e! 1!diazepines and their use in the treatment of HIV-1 infection

Also Published As

Publication number Publication date
EE200200690A (et) 2004-06-15
JP2004502787A (ja) 2004-01-29
EA200201255A1 (ru) 2003-06-26
ES2261433T3 (es) 2006-11-16
EP1294720B1 (de) 2006-04-05
EA005598B1 (ru) 2005-04-28
EP1294720A1 (de) 2003-03-26
BG107348A (bg) 2004-06-30
KR20030017540A (ko) 2003-03-03
AU7037001A (en) 2001-12-24
HRP20021003A2 (en) 2005-02-28
MXPA02012205A (es) 2003-09-10
HUP0301105A2 (hu) 2003-08-28
UA74834C2 (en) 2006-02-15
SK17722002A3 (sk) 2003-06-03
AR028958A1 (es) 2003-05-28
US20020028807A1 (en) 2002-03-07
DE60118560T2 (de) 2006-09-28
AU2001270370B2 (en) 2006-08-03
CN1436189A (zh) 2003-08-13
NO20025844D0 (no) 2002-12-05
PL360370A1 (en) 2004-09-06
CA2411766C (en) 2006-05-23
ZA200209807B (en) 2003-10-16
CA2411766A1 (en) 2001-12-20
YU94202A (sh) 2005-11-28
NO323830B1 (no) 2007-07-09
DK1294720T3 (da) 2006-07-31
US6420359B1 (en) 2002-07-16
PT1294720E (pt) 2006-06-30
PE20020083A1 (es) 2002-02-28
JP3923894B2 (ja) 2007-06-06
ATE322492T1 (de) 2006-04-15
NO20025844L (no) 2002-12-05
BR0102377A (pt) 2002-02-19
UY26767A1 (es) 2002-01-31
CN1178939C (zh) 2004-12-08
NZ523549A (en) 2004-08-27
TWI270547B (en) 2007-01-11
IL152819A0 (en) 2003-06-24
MY130375A (en) 2007-06-29
CZ20024114A3 (cs) 2003-04-16
WO2001096338A1 (en) 2001-12-20
HK1057558A1 (en) 2004-04-08
SA01220202B1 (ar) 2006-09-05

Similar Documents

Publication Publication Date Title
ATE433451T1 (de) Xanthin-phosphodiesteras-v-inhibitoren
AR028253A1 (es) Inhibidores de la glucogeno fosforilasa
IS6668A (is) Kolkínólafleiður sem æðamyndunarhemlar
PL378556A1 (pl) Nienukleozydowe inhibitory odwrotnej transkryptazy
HK1080849A1 (en) Non-nucleoside reverse transcriptase inhibitors
DE60117597D1 (de) Aufweitvorrichtung
NO20024997D0 (no) 2-guanidino-4-arylkinazoliner som NHE-3-inhibitorer
IL144349A0 (en) Non-nucleoside reverse transcriptase inhibitors
DK1272488T3 (da) Tri-aryl-substitueret ethan-PDE4-inhibitorer
HK1111155A1 (en) Non-nucleoside reverse transcriptase inhibitors
ATE322492T1 (de) Nicht-nukleosid reverse transkriptase inhibitoren
DE60139831D1 (de) Sicherung
DE60133976D1 (de) Turbomaschinen
ATE276445T1 (de) Spreizdübel
PT1339695E (pt) Inibidores da farnesiltransferase
ATE351991T1 (de) Spreizdübel
AR028075A1 (es) Inhibidores de la peptido-desformilasa
DE60132468D1 (de) Alen-lanosterol zyklase inhibitoren
ATE331898T1 (de) Spreizdübel
EP1326640A4 (de) Nichtnucleosidischer reverse-transcriptase-hemmer als antiretrovirale therapie
DE60142585D1 (de) Fischer-tropsch-verfahren
DE60137845D1 (de) Rauscharmes spektroskopisches ellipsometer
DK1373267T3 (da) Non-nucleoside revers transkriptase-inhibitorer
SI1294720T1 (sl) Nenukleozidni inhibitorji reverzne transkriptaze
AT500315A3 (de) Gitterrost

Legal Events

Date Code Title Description
8364 No opposition during term of opposition